CHARLES SCHWAB INVESTMENT MANAGEMENT INC - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 24 filers reported holding MOLECULIN BIOTECH INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q4 2022$38,802
-15.6%
36,606
+16.4%
0.00%
Q2 2022$46,000
+27.8%
31,454
+55.7%
0.00%
Q1 2022$36,000
-5.3%
20,1980.0%0.00%
Q4 2021$38,000
-37.7%
20,1980.0%0.00%
Q3 2021$61,000
+22.0%
20,198
+66.0%
0.00%
Q1 2021$50,00012,1670.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,036,853$1,099,0640.41%
JMAC ENTERPRISES LLC 13,132$13,9200.00%
Virtu Financial LLC 13,791$150.00%
Sigma Planning Corp 57,500$60,9500.00%
VANGUARD GROUP INC 1,080,122$1,144,9300.00%
UBS Group AG 11,243$11,9180.00%
MASSMUTUAL TRUST CO FSB/ADV 167$00.00%
OSAIC HOLDINGS, INC. 968$1,3540.00%
FMR LLC 2$20.00%
BANK OF AMERICA CORP /DE/ 6,683$7,0840.00%
View complete list of MOLECULIN BIOTECH INC shareholders